Powerful Seizure Control. Proven Safety.
Indications:
- Partial-onset seizures – from 1 month of age
- Myoclonic seizures – in juvenile myoclonic epilepsy (≥12 yrs)
- Primary generalized tonic-clonic seizures – in idiopathic generalized epilepsy (≥6 yrs)
- Monotherapy – for partial-onset seizures in adults & adolescents (≥16 yrs)
- Off-label uses: Status epilepticus, seizure prophylaxis (SAH/TBI), neurosurgery, palliative care
Mechanism of Action:
- Selectively binds SV2A → stabilizes neurotransmitter release
- Modulates vesicle fusion & exocytosis → prevents abnormal neuronal firing
- Influences Ca²⁺ channels, GABA & AMPA pathways
- Provides neuroprotective, anti-inflammatory & antioxidant benefits
Clinical Advantages:
✅ Broad-spectrum seizure control
✅ Minimal drug interactions
✅ Excellent tolerability & safety profile
✅ Suitable for long-term therapy
Note: To be used only under the guidance of a registered medical practitioner.
LEVICRON™ — Trusted Protection for Every Seizure Type
